Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
33,092,097
-
Share change
-
-284,595
-
Total reported value
-
$98,277,480
-
Put/Call ratio
-
156%
-
Price per share
-
$2.97
-
Number of holders
-
35
-
Value change
-
+$349,190
-
Number of buys
-
14
-
Number of sells
-
19
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q1 2023
As of 31 Mar 2023,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,092,097 shares.
The largest 10 holders included
BVF INC/IL, Bellevue Group AG, PFM Health Sciences, LP, Soleus Capital Management, L.P., MORGAN STANLEY, ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, MILLENNIUM MANAGEMENT LLC, and Rhenman & Partners Asset Management AB.
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.